Study of RNA Interference Targeting NET-1 Combination with Sorafenib for Hepatocellular Carcinoma Therapy In Vitro and In Vivo

The aim of this study is to explore the inhibitory effects of RNA interference (RNAi) targeting NET-1 or combined with sorafenib on HCC in vitro and in vivo and the possible underlying mechanisms. The expressions of NET-1 mRNA and protein were detected by RT-QPCR and western blot. The ability of pro...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Song, Wei, Ying-ze, Wang, Gui-lan, Xu, Yu-yin, Zhou, Jia-ming, Zhang, Yi-xin, Chen, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838818/
https://www.ncbi.nlm.nih.gov/pubmed/24307893
http://dx.doi.org/10.1155/2013/685150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3838818/
https://www.ncbi.nlm.nih.gov/pubmed/24307893
http://dx.doi.org/10.1155/2013/685150

Ejemplares similares